Accelerating the Implementation of Mass Spectrometry in the Clinical Lab

CMS Logo MSACL

UNITED STATES 2019

Help Us Reach Our Educational Support Goal of $40,000
Educational Grants supported in part by:
Brian Kelly
Danyel Tacker
Amadeo Pesce

Meet-a-Mentor

MSACL strives to offer a congress experience that values training and mentorship (see travel grants, short courses and Practical Training tracks), and provides avenues by which early-career attendees can gain experience presenting (see Poster Lightning Talks, the Poster Contest, Podium opportunities).

The Meet-a-Mentor program has been developed to create a channel by which early-career attendees can approach, interact and connect with mid- to late-career attendees to share intellect and experience.

Booth and Poster Tours: Mentors browse booths or view posters as they normally do, but with one or more mentees along to observe, participate and learn from experience.

Office Hours: Mentors will be available at tables in the Meet-a-Mentor area of the Exhibit Hall where attendees can sign up to have a 10-15 minute chat about ... anything.

You can sign up at the congress to participate in one or more Meet-a-Mentor activities (i.e., Booth Tour, Poster Tour, Office Hours).

Tuesday 18:00 - 19:00 Meet-a-Mentor: Booth Tours
Exhibit Hall in Oasis 3-4
Wednesday 14:15 - 15:00 Meet-a-Mentor: Poster Tours 1
Exhibit Hall in Oasis 3-4
Wednesday 16:15 - 17:15 Meet-a-Mentor: Office Hours 1
Exhibit Hall in Oasis 3-4
Thursday 10:15 - 11:00 Meet-a-Mentor: Poster Tours 2
Exhibit Hall in Oasis 3-4

William Clarke, PhD
Johns Hopkins University

Booth Tours on Tuesday @ 18:00
Office Hours 1 on Wednesday @ 16:15
Dr. William Clarke is a professor of pathology at the Johns Hopkins University School of Medicine. His research focuses on the development of analytical methods for drug analysis, clinical mass spectrometry, and devices for point-of-care testing. Dr. Clarke serves as the director of Clinical Toxicology as well as Critical and Point-of-Care Testing Program at The Johns Hopkins Hospital.

His team’s current projects include qualitative screening for antiretroviral drugs and substances of abuse in various HIV- prevention clinical trials, development and validation of mass spectrometry methods for clinical analysis, and development of clinical assays for use on microfluidic platforms.

Dr. Clarke received his B.S. in Chemistry from the University of Nebraska at Kearney and his Ph.D. in Analytical Chemistry from the University of Nebraska-Lincoln, as well as an M.B.A. from the Carey School of Business at Johns Hopkins University. He completed a post-doctoral fellowship in Clinical Chemistry at the Johns Hopkins School of Medicine.